Icon Advisers Inc. Co. Has $2,078,000 Stake in Teleflex Incorporated (TFX)
Icon Advisers Inc. Co. held its stake in shares of Teleflex Incorporated (NYSE:TFX) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 10,000 shares of the medical technology company’s stock at the end of the second quarter. Icon Advisers Inc. Co.’s holdings in Teleflex were worth $2,078,000 at the end of the most recent quarter.
Several other institutional investors have also modified their holdings of the company. Vanguard Group Inc. boosted its stake in shares of Teleflex by 5.2% during the 1st quarter. Vanguard Group Inc. now owns 3,781,475 shares of the medical technology company’s stock worth $732,584,000 after acquiring an additional 186,845 shares during the last quarter. State Street Corp boosted its stake in shares of Teleflex by 3.2% during the 1st quarter. State Street Corp now owns 1,374,521 shares of the medical technology company’s stock worth $266,280,000 after acquiring an additional 42,014 shares during the last quarter. American Century Companies Inc. boosted its stake in shares of Teleflex by 22.8% during the 2nd quarter. American Century Companies Inc. now owns 839,080 shares of the medical technology company’s stock worth $174,327,000 after acquiring an additional 155,863 shares during the last quarter. FMR LLC boosted its stake in shares of Teleflex by 46.5% during the 1st quarter. FMR LLC now owns 811,764 shares of the medical technology company’s stock worth $157,263,000 after acquiring an additional 257,649 shares during the last quarter. Finally, Principal Financial Group Inc. boosted its stake in shares of Teleflex by 93.5% during the 2nd quarter. Principal Financial Group Inc. now owns 610,398 shares of the medical technology company’s stock worth $126,816,000 after acquiring an additional 294,935 shares during the last quarter. Institutional investors and hedge funds own 90.50% of the company’s stock.
Teleflex Incorporated (NYSE TFX) opened at 235.23 on Friday. The stock has a market cap of $10.59 billion, a PE ratio of 44.99 and a beta of 1.05. The company’s 50 day moving average is $214.79 and its 200-day moving average is $204.26. Teleflex Incorporated has a 1-year low of $136.53 and a 1-year high of $236.02.
Teleflex (NYSE:TFX) last posted its quarterly earnings data on Thursday, August 3rd. The medical technology company reported $2.04 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.91 by $0.13. The business had revenue of $528.60 million for the quarter, compared to the consensus estimate of $518.98 million. Teleflex had a net margin of 12.36% and a return on equity of 16.12%. The company’s revenue was up 11.6% compared to the same quarter last year. During the same period last year, the firm posted $1.89 earnings per share. Equities research analysts forecast that Teleflex Incorporated will post $8.28 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which was paid on Friday, September 15th. Shareholders of record on Tuesday, August 15th were issued a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 0.58%. The ex-dividend date of this dividend was Friday, August 11th. Teleflex’s payout ratio is 26.00%.
In related news, Director Gretchen R. Haggerty acquired 1,000 shares of the firm’s stock in a transaction on Wednesday, June 21st. The shares were acquired at an average cost of $203.82 per share, with a total value of $203,820.00. Following the completion of the acquisition, the director now directly owns 1,760 shares in the company, valued at approximately $358,723.20. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Stephen K. M.D. Klasko sold 200 shares of the stock in a transaction on Monday, July 3rd. The shares were sold at an average price of $208.10, for a total transaction of $41,620.00. Following the transaction, the director now directly owns 8,080 shares in the company, valued at $1,681,448. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 600 shares of company stock worth $125,652. Insiders own 2.39% of the company’s stock.
WARNING: This story was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this story on another site, it was illegally stolen and republished in violation of international copyright & trademark laws. The legal version of this story can be viewed at https://www.thecerbatgem.com/2017/09/16/icon-advisers-inc-co-has-2078000-stake-in-teleflex-incorporated-tfx.html.
Several research analysts have recently weighed in on TFX shares. Zacks Investment Research upgraded shares of Teleflex from a “hold” rating to a “buy” rating and set a $261.00 price target on the stock in a research note on Tuesday. Leerink Swann lifted their price target on shares of Teleflex from $215.00 to $220.00 and gave the stock a “market perform” rating in a research note on Friday, June 9th. BidaskClub cut shares of Teleflex from a “hold” rating to a “sell” rating in a research note on Tuesday, August 8th. Barclays PLC reiterated an “overweight” rating and set a $253.00 price target (up previously from $230.00) on shares of Teleflex in a research note on Tuesday. Finally, Needham & Company LLC reiterated a “buy” rating on shares of Teleflex in a research note on Friday, August 4th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and eight have assigned a buy rating to the company. Teleflex currently has an average rating of “Buy” and an average price target of $257.00.
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).
Receive News & Stock Ratings for Teleflex Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Incorporated and related stocks with our FREE daily email newsletter.